NO920263L - Kontrastmediumblanding - Google Patents

Kontrastmediumblanding

Info

Publication number
NO920263L
NO920263L NO92920263A NO920263A NO920263L NO 920263 L NO920263 L NO 920263L NO 92920263 A NO92920263 A NO 92920263A NO 920263 A NO920263 A NO 920263A NO 920263 L NO920263 L NO 920263L
Authority
NO
Norway
Prior art keywords
contrast media
media mix
mix
contrast medium
enhancing agent
Prior art date
Application number
NO92920263A
Other languages
English (en)
Other versions
NO303483B1 (no
NO920263D0 (no
Inventor
Helge Guttorm Gundersen
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed As filed Critical Nycomed As
Publication of NO920263L publication Critical patent/NO920263L/no
Publication of NO920263D0 publication Critical patent/NO920263D0/no
Publication of NO303483B1 publication Critical patent/NO303483B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1887—Agglomerates, clusters, i.e. more than one (super)(para)magnetic microparticle or nanoparticle are aggregated or entrapped in the same maxtrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1803—Semi-solid preparations, e.g. ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Liquid Crystal Substances (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO920263A 1989-07-21 1992-01-20 Kontrastmediumblanding, anvendelse og diagnostisk kontrastmiddelsett NO303483B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898916780A GB8916780D0 (en) 1989-07-21 1989-07-21 Compositions
PCT/EP1990/001196 WO1991001148A1 (en) 1989-07-21 1990-07-19 Contrast medium composition

Publications (3)

Publication Number Publication Date
NO920263L true NO920263L (no) 1992-01-20
NO920263D0 NO920263D0 (no) 1992-01-20
NO303483B1 NO303483B1 (no) 1998-07-20

Family

ID=10660459

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920263A NO303483B1 (no) 1989-07-21 1992-01-20 Kontrastmediumblanding, anvendelse og diagnostisk kontrastmiddelsett

Country Status (16)

Country Link
EP (2) EP0409351B1 (no)
JP (1) JP2962521B2 (no)
AT (1) ATE101047T1 (no)
AU (1) AU640401B2 (no)
CA (1) CA2059279A1 (no)
DE (1) DE69006415T2 (no)
DK (1) DK0409351T3 (no)
ES (1) ES2048958T3 (no)
FI (1) FI98987C (no)
GB (1) GB8916780D0 (no)
HK (1) HK1003562A1 (no)
IE (1) IE65463B1 (no)
NO (1) NO303483B1 (no)
NZ (1) NZ234574A (no)
WO (1) WO1991001148A1 (no)
ZA (1) ZA905725B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
DE69131721T2 (de) * 1990-04-10 2000-03-02 Imarx Pharmaceutical Corp., Tucson Polymere als Kontrastmittel bei magnetischer Resonanz
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5370901A (en) * 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
US5179955A (en) * 1991-02-22 1993-01-19 Molecular Biosystems, Inc. Method of abdominal ultrasound imaging
US5455308A (en) * 1991-08-01 1995-10-03 Dsm N.V. Endless objects from epoxy resin or unsaturated polyester and thermoplastic polymer
JPH06157355A (ja) * 1992-11-13 1994-06-03 Dai Ichi Seiyaku Co Ltd Ｍｒｉ用粒状製剤
FR2703250A1 (fr) * 1993-03-30 1994-10-07 Chicouri Marcel Nouvelles compositions pharmaceutiques à base de bismuth et leur procédé de préparation.
DE4426204C2 (de) * 1993-07-24 2001-05-23 Infai Inst Fuer Biomedizinisch Diagnostikum und seine Verwendung
JP2909876B2 (ja) * 1994-01-24 1999-06-23 恭弘 小川 造影剤
CA2182213A1 (en) * 1994-01-28 1995-08-03 William George Gorman Oral magnetic particle formulation
EP1031354A3 (en) 1999-01-19 2003-02-05 Rohm And Haas Company Polymeric MRI Contrast agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
SE463651B (sv) 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3577185D1 (de) * 1984-11-01 1990-05-23 Nycomed As Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
DE3443252A1 (de) 1984-11-23 1986-05-28 Schering AG, 1000 Berlin und 4709 Bergkamen Dextran-magnetit-komplexe fuer die nmr-diagnostik
US4675173A (en) 1985-05-08 1987-06-23 Molecular Biosystems, Inc. Method of magnetic resonance imaging of the liver and spleen
US4729892A (en) 1986-03-21 1988-03-08 Ciba-Geigy Corporation Use of cross-linked hydrogel materials as image contrast agents in proton nuclear magnetic resonance tomography and tissue phantom kits containing such materials
US4770183A (en) 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
SE8704157L (sv) 1987-10-26 1989-04-27 Carbomatrix Ab C O Ulf Schroed Superparamagnetiska partiklar och foerfarande foer framstaellning daerav samt anvaendning

Also Published As

Publication number Publication date
JP2962521B2 (ja) 1999-10-12
JPH04506806A (ja) 1992-11-26
CA2059279A1 (en) 1991-01-22
AU640401B2 (en) 1993-08-26
IE902658A1 (en) 1991-02-27
FI920237A0 (fi) 1992-01-20
EP0409351B1 (en) 1994-02-02
DE69006415T2 (de) 1994-05-11
IE65463B1 (en) 1995-11-01
EP0409351A1 (en) 1991-01-23
AU6147590A (en) 1991-02-22
FI98987B (fi) 1997-06-13
DE69006415D1 (de) 1994-03-17
HK1003562A1 (en) 1998-10-30
ATE101047T1 (de) 1994-02-15
ZA905725B (en) 1991-04-24
WO1991001148A1 (en) 1991-02-07
ES2048958T3 (es) 1994-04-01
EP0485429A1 (en) 1992-05-20
NO303483B1 (no) 1998-07-20
GB8916780D0 (en) 1989-09-06
DK0409351T3 (da) 1994-03-07
NZ234574A (en) 1992-11-25
FI98987C (fi) 1997-09-25
NO920263D0 (no) 1992-01-20

Similar Documents

Publication Publication Date Title
NO920263D0 (no) Kontrastmediumblanding
EP0500941A4 (en) Novel composite and emulsion composition
NO920261D0 (no) Kontrastmedier
TR24655A (tr) Karbon isleri ve karbon islerini iceren kaucuk bilesimleri
AU2017488A (en) Antifoam agents
GB8916782D0 (en) Compositions
ATE109962T1 (de) Polyalkylenoxidderivate enthaltende polyetherabformmassen.
JO1637B1 (en) Contrast media (oxygen saruration)
ES2157267T3 (es) Procedimiento y reactivo para la determinacion de hierro.
EP0227074A3 (en) Aminocarboxylic acid-terminated polyoxyalkylene containing extreme pressure functional compositions
FI852008L (fi) Faergframkallande komposition och uppteckningsmaterial innehaollande kompositionen.
DE3573393D1 (en) Colour developer composition and record material carrying the composition
ATE245829T1 (de) Lichtempfindliche zusammensetzung und verfahren zur herstellung von mustern
DE59105701D1 (de) Modulator- und Mischstufe.
AU2459195A (en) Photopolymerizable composition
ES1031984U (es) Expositor perfeccionado.
FR2671122B3 (fr) Plaque d'etancheite.
ES1031669U (es) Expositor perfeccionado.
ZA86429B (en) "(alpha,omega-bis(diphenylphosphino)hydrocarbon)bis((thiosugar)-gold)and bis((selenosugar)gold)derivatives
DE3481868D1 (de) Mikrofilm-einlege- und projektionsgeraet.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2001